Tumors arising in the RASLO mice treated with AdCre comprised multiple papillary adenomas and invasive papillary adenocarcinomas (Fig. 1E), which is consistent with KRAS driven lung cancer models described previously [4], [20]. The gene discussed is KRAS; the disease is papillary adenoma.